Sonorant Therapeutics

Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff
Endpoints
Tue, 08/6/19 - 01:05 pm
Mallinckrodt
opioids
generics
Sonorant Therapeutics
SpecGx